100 Results Way
Fax: 1-877-295 -8102
About GE Healthcare
GE Healthcare Life Sciences
The Life Sciences business of GE Healthcare exists to enable and accelerate molecular and precision medicine. We do this by helping our customers discover, make and use new medicines.
Healthcare needs more precise diagnoses and treatments to improve patient outcomes, address the globally rising incidence of lifestyle and chronic diseases, and help reduce the $350 billion wasted each year on poorly-targeted medicines.
We empower researchers with the innovative tools and analytics to research and develop tomorrow’s therapeutics.
We drive productivity for the biopharmaceutical industry and help create manufacturing capacity in under-served markets.
We enable increasingly accurate diagnoses by providing advanced in vivo imaging agents & in vitro diagnostics.
We are helping create the future of regenerative medicine and cell therapy with customers by providing novel tools, technologies and methods.
We work on the things that matter to become trusted partners with our customers, combining our deep expertise, integrity, and heritage in diagnostics and biotechnology with an extensive global network and strength in infrastructure and services.
We are a $4.0 billion business of GE Healthcare serving researchers, pharmaceutical companies, and clinicians.
The Story: GE Healthcare Life Sciences
338 articles with GE Healthcare
GE Healthcare is collaborating with the American College of Cardiology through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for Artificial Intelligence and digital technology in cardiology and developing new strategies for improved health outcomes.
Fit for the COVID Fight: GE Healthcare Expands Ultrasound Family with New Point of Care System and AI Offering
Driven by pandemic realities and clinical demand for portable and intelligent point-of-care ultrasound, GE Healthcare unveiled Venue Fit™, a streamlined and compact POCUS system, alongside an industry-first AI offering for cardiac imaging on the Venue™ and Venue Go™.
After acquiring the Molecular Breast Imaging assets from GE Healthcare and Dilon Technologies, Inc., SmartBreast Corporation, a privately held company focused on breast cancer screening and diagnosis, announced that it has formed a partnership with FoxSemicon Integrated Technologies, Inc. to manufacture Molecular Breast Imaging systems.
GE Healthcare Expands AI, Digital and Imaging Solutions at #RSNA2020, Helping Shape Future of Healthcare in the COVID Era
GE Healthcare unveiled a slate of new intelligently efficient solutions to help clinicians solve today’s two-part challenge of delivering high quality care while managing greater capacity and workflow issues, exacerbated by the impact of COVID-19.
GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT)
GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the World
GE Healthcare, GenesisCare Partner to Tackle Two Biggest Health Burdens Globally, Deliver Improved Cancer and Cardiovascular Care to Patients Around the World The multi-year strategic partnership will enable GenesisCare to offer patients greater access to leading technology, with a plan to explore further collaborations to improve cancer diagnosis, treatment and cardiovascular care
Tampa General Hospital and GE Healthcare's CareComm Saves $40 Million, Cuts 20,000 Excess Days and Reduces Length of Stay
Tampa General Hospital, in partnership with GE Healthcare, reports a $40M reduction of system-wide inefficiencies since launching their CareComm command center with GE’s Command Center Software last August.
St. Luke’s University Health Network Selects GE Healthcare for $11 Million Ultrasound Purchase to Create System-wide Efficiencies
GE Healthcare will install 76 ultrasound systems in 2020 to deploy a fleet of AI-powered technology, making this GE Healthcare’s largest ever single-order ultrasound deal in the U.S.
GE Healthcare Introduces New Edge Technology Designed to Give Clinicians Rapid Access to Critical Data
GE Healthcare today introduced Edison HealthLink, new edge computing technology designed specifically for the needs of healthcare providers, that allows clinicians to collect, analyze and act upon critical data closer to its source. With 10 applications already available through Edison HealthLink – including TrueFidelity image reconstruction, Mural Virtual Care and CT Smart Subscription – the solution gives healthcare prov
GE Healthcare Receives FDA Clearance for Vivid Ultra Edition, AI-Powered Cardiovascular Ultrasound System Designed to Shorten Diagnostic Exam Time and Improve Measurement Consistency
GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid 1 cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of heart function are key in echocardiography but can be tedious and time-consuming to acquire. High quality data acquisition and
SyntheticMR announced that they have signed an agreement with GE Healthcare to integrate their quantitative MRI solution SyMRI in GE's platform.
GE Healthcare’s Clariscan™ (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle
US FDA approves +PLUSPAK™ (polymer bottle) Pharmacy Bulk Package for the gadolinium-based contrast agent, Clariscan™ (gadoterate meglumine) As the only polymer bottle for an MRI contrast agent, Clariscan in +PLUSPAK offers the potential for increased workplace safety, efficiency, convenience and environmental advantages Clariscan has been approved in more than 65 countries globally, with more than six million patient doses shipped
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)
GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare's range of iodinated x-ray contrast media, offer healthcar
Shorter Scans and Better Image Quality: Deep Learning-Based MR Image Reconstruction Tech From GE Healthcare Now FDA Cleared
AIR Recon DL is MR industry’s first 510(k)-cleared, deep learning-based image reconstruction technology that works across all anatomies
Ecolog and GE Healthcare in Germany Signed a Memorandum of Understanding to Join Forces in Combating COVID-19 Pandemic
Ecolog's Eco-Care Solution is aimed at addressing the much-needed relief and recovery in addressing COVID-19 pandemic
Getinge Contributes to Ventilator Manufacturers Group to Form Ventilator Training Alliance and Create App to Help Frontline Medical Workers During COVID-19 Pandemic
Several of the world's ventilator manufacturers announce a newly formed Ventilator Training Alliance to support frontline medical providers to access a centralized repository of ventilator training.
GE Healthcare Deploys Remote Patient Data Monitoring Technology to Help Clinicians Support Most Critical COVID-19 Patients across the Health System
GE Healthcare today introduced a new software solution to support clinicians and health systems in the treatment of COVID-19 patients. The company is bringing its Mural Virtual Care Solution, which i
Ford to Produce 50,000 Ventilators in Michigan in Next 100 Days; Partnering with GE Healthcare Will Help Coronavirus Patients
Ford Motor Company, in collaboration with GE Healthcare, announced it will begin producing in Michigan a third-party ventilator with the goal to produce 50,000 of the vitally needed units within 100 days and up to 30,000 a month thereafter as needed.
GE Healthcare and Ford collaborate to accelerate and scale ventilator production, supporting clinicians in the treatment of COVID-19 patients
GE Healthcare President & CEO Kieran Murphy issued the following statement around efforts to address the coronavirus